21.07.2020 • NewsBASFThyssenkruppDede Willams

BASF and Thyssenkrupp in JDA for STAR Process

BASF and Thyssenkrupp have signed a joint development agreement to expand their cooperation on the Thyssenkrupp’s Steam Active Reforming (STAR process). The engineering group’s proprietary dehydrogenation process is used to produce propylene from propane feedstocks or iso-butylene from iso-butane feedstocks, using an exceptionally stable catalyst.

With Thyssenkrupp focusing on process development and BASF on catalyst development, the two German industrial giants said the aim is to “significantly increase” the resource and energy efficiency of the reforming process for plant operators.

Targeted improvements in catalyst and plant design should result in less feedstock consumption and reduced investment and operating costs as well lower CO2 emissions, the partners believe. Changes could include new catalyst shapes and a smaller reformer design, which in turn could lower the investment costs of propylene dehydrogenation plants, Thyssenkrupp said.

“This project is a good example of how technology development can be accelerated through cross-sector collaboration,” said Adrian Steinmetz, vice president Global Chemical Catalysts & Adsorbents at BASF. Toward the goal of reducing the cost of the catalyst, feedstock and energy consumption, as well as lowering the CO2 footprint, he said the companies will specifically address topics such as reducing precious metal content.

BASF and thyssenkrupp are expanding their cooperation on Thyssenkrupp’s Steam...
BASF and thyssenkrupp are expanding their cooperation on Thyssenkrupp’s Steam Active Reforming (STAR) process for propylene dehydrogenation. With the aim of saving resources and energy and lowering CO2 output, thyssenkrupp will focus on process development, BASF on catalysts. (c) thyssenkrupp

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.